Trials / Completed
CompletedNCT04359368
Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions
Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions - a Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 42 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate characteristics of patients with previous hypersensitivity reaction grades I-IV to intravenous ferric carboxymaltose (Ferinject) or to iron sucrose (Venofer) including age, atopy status, previous allergic reactions, previous medical history, current medications and co-morbidities. Furthermore, symptoms on reaction such as severity grade of reaction will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | collection of patient data | Data collection (history, clinical presentation, medication, complications, laboratory testing) will be performed from patient records stored in the protected electronic patient system ISMed (Integrated System for Medical Diagnostic) of patients with HSRs to NDIPs. |
Timeline
- Start date
- 2019-09-01
- Primary completion
- 2019-10-31
- Completion
- 2019-10-31
- First posted
- 2020-04-24
- Last updated
- 2020-04-24
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04359368. Inclusion in this directory is not an endorsement.